Key points are not available for this paper at this time.
In previous studies (17-21), monoclonal antibody (mAb) 9.3 has been shown to react with a major population of human T cells, which include T4+ helper/inducer T cells and T8+ cytotoxic T cells. In this investigation, mAb 9.3 was shown to precipitate a disulfide-bonded dimer of a 44 kD polypeptide. Comodulation experiments showed that this molecule is not linked to T3/Ti or T11 antigens. mAb 9.3 was capable of inducing T cell proliferation in the presence of 12-o-tetradecanoyl phorbol-13-acetate (TPA). This effect was monocyte-independent. T cell activation with mAb 9.3 and TPA was associated with increases in interleukin 2(IL-2) receptor expression and IL-2 secretion. mAb 9.3 did not activate T cells, even with the addition of IL-1 or IL-2. Modulation of the T3 complex did not abolish mAb 9.3-induced T cell proliferation in the presence of TPA. These results suggest that the 9.3 antigen may serve as a receptor for an activation pathway restricted to a T cell subset.
Building similarity graph...
Analyzing shared references across papers
Loading...
Takahiro Hara
Kyoto University
Shu Man Fu
Intensive Care Foundation
John A. Hansen
Roskilde University
The Journal of Experimental Medicine
Oklahoma Medical Research Foundation
Bloodworks Northwest
Building similarity graph...
Analyzing shared references across papers
Loading...
Hara et al. (Sat,) studied this question.
synapsesocial.com/papers/6a0c43293b45b6e808886669 — DOI: https://doi.org/10.1084/jem.161.6.1513